Sunflower Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sunflower Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Guizhou Yibai Pharmaceutical Co., Ltd.
sales of 3.81 billion Chinese Renmimbi [US$562.70 million]
of which 81%
was Medical Industry),
Renhe Pharmacy Company Limited
(3.84 billion Chinese Renmimbi [US$567.95 million]
of which 98%
was Medicine), and
Jiuzhitang Company Limited
(3.84 billion Chinese Renmimbi [US$566.97 million]
of which 102%
was Pharmacuetical Industry).
Sunflower Pharmaceutical Group Co Ltd reported sales of 3.85 billion Chinese Renmimbi (US$569.66 million)
December of 2017.
increase of 14.7%
versus 2016, when the company's sales were 3.36 billion Chinese Renmimbi.
Sales at Sunflower Pharmaceutical Group Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 118%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
39.0% in 2017, from
74.04 million Chinese Renmimbi to 102.92 million Chinese Renmimbi.
Not all segments of Sunflower Pharmaceutical Group Co Ltd experienced an increase in sales in 2017:
sales of Other Business fell 56.5% to 3.27 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).